Table 2.
Character of CML patients
| Case | Sex | Age | Diagnosis | Cytogenetic |
|---|---|---|---|---|
| 1 | M | 38 | CML | t(9;22),i(17q) |
| 2 | F | 48 | CML | t(9;22) |
| 3 | M | 47 | CML | t(9;22), -Y |
| 4 | M | 37 | CML | Complex |
| 5 | F | 33 | CML | t(9;22) |
| 6 | M | 46 | CML | t(9;22) |
| 7 | M | 43 | CML | t(9;22) |
| 8 | F | 56 | CML | t(9;22),der(15)t(1;15) |
| 9 | M | 27 | CML | t(9;22) |
| 10 | M | 41 | CML | Complex |
| 11 | F | 62 | CML | t(9;22) |
| 12 | M | 51 | CML | t(9;22) |
| 13 | F | 54 | CML | t(9;22) |
| 14 | M | 28 | CML | t(9;22) |
| 15 | F | 43 | CML | Complex |
| 16 | M | 56 | CML | Complex |
| 17 | F | 60 | CML | t(9;22) |
| 18 | F | 65 | CML | t(9;22) |
| 19 | M | 27 | CML | Complex |
| 20 | F | 40 | CML | t(9;22) |
| 21 | M | 50 | CML | t(9;22) |
| 22 | F | 55 | CML | inv(9),t(9;22) |
| 23 | F | 58 | CML | t(9;22) |
| 24 | M | 47 | CML | t(9;22) |
| 25 | M | 41 | CML | t(9;22) |
| 26 | M | 53 | CML | Complex |
| 27 | M | 24 | CML-BP | Complex |
| 28 | F | 48 | CML-BP | Complex |
| 29 | F | 65 | CML-BP | Complex |
| 30 | M | 28 | CML-BP | Complex |
| 31 | M | 50 | CML-BP | Complex |
| 32 | M | 40 | CML-BP | Complex |
| 33 | F | 47 | CML-BP | t(9;22) |
| 34 | M | 35 | CML-BP | t(9;22) |
| 35 | M | 53 | CML-BP | Complex |
| 36 | F | 34 | CML-BP | Complex |
| 37 | M | 57 | CML-BP | t(9;22) |
| 38 | M | 40 | CML-BP | Complex |
| 39 | M | 46 | CML-BP | Complex |
| 40 | M | 40 | CML-BP | t(9;22) |
| 41 | M | 26 | CML-BP | t(9;22) |
| 42 | M | 47 | CML-BP | Complex |
| 43 | M | 52 | CML-BP | Complex |
| 44 | F | 46 | CML-BP | t(9;22) |
| 45 | M | 30 | CML-BP | t(9;22) |
| 46 | M | 36 | CML-BP | t(9;22), +8 |
| 47 | M | 36 | CML-BP | Complex |
| 48 | F | 17 | CML-BP | t(9;22) |
CML: chronic myeloid leukaemia.
CML-BP: chronic myeloid leukaemia in blast phase.
“complex” means more than two abnormities.